Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Bank Albilad Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Bank Albilad şirketinin toplam varlıkları SAR145.3B ve toplam özkaynağı SAR15.8B dır. Toplam mevduat SAR118.9B ve toplam krediler SAR104.3B dır.

Anahtar bilgiler

9.2x

Varlık/özkaynak oranı

n/a

Net faiz marjı

Toplam mevduat	ر.س118.85b
Kredi/mevduat oranı	Uygun
Batık krediler	1.3%
Sorunlu krediler için ayrılan karşılık	Yeterli
Cari oran	Düşük
Nakit ve eşdeğerleri	ر.س7.23b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Here's Why We Think Bank Albilad (TADAWUL:1140) Might Deserve Your Attention Today

Sep 20

Here's Why We Think Bank Albilad (TADAWUL:1140) Might Deserve Your Attention Today

May 31

Here's Why We Think Bank Albilad (TADAWUL:1140) Is Well Worth Watching

Feb 05

Bank Albilad (TADAWUL:1140) Ticks All The Boxes When It Comes To Earnings Growth

Oct 23

Here's Why We Think Bank Albilad (TADAWUL:1140) Is Well Worth Watching

Jul 07

If EPS Growth Is Important To You, Bank Albilad (TADAWUL:1140) Presents An Opportunity

Mar 22

Investors Who Bought Bank Albilad (TADAWUL:1140) Shares Five Years Ago Are Now Up 87%

Feb 14

What Type Of Shareholders Own The Most Number of Bank Albilad (TADAWUL:1140) Shares?

Jan 18

What Makes Bank Albilad (TADAWUL:1140) A Great Dividend Stock?

Dec 23

Do Bank Albilad's (TADAWUL:1140) Earnings Warrant Your Attention?

Nov 27

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Finansal Kurumlar Analizi

Varlık Seviyesi: 1140 'nin Varlık/Özsermaye oranı ( 9.2 x) düşüktür.

Kötü Krediler İçin Ödenek: 1140 yeterli kötü krediler için bir ödeneği var ( 203 %).

Düşük Riskli Yükümlülükler: 1140 'un yükümlülüklerinin 92% 'i esas olarak düşük riskli finansman kaynaklarından oluşmaktadır.

Kredi Seviyesi: 1140 Kredi/Varlık oranı açısından uygun bir seviyeye sahiptir ( 72% ).

Düşük Riskli Mevduatlar: 1140 'nin Kredi/Mevduat oranı ( 88% ) uygundur.

Kötü Kredilerin Seviyesi: 1140 uygun düzeyde kötü krediler içeriyor ( 1.3 %).

Bank Albilad Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Here's Why We Think Bank Albilad (TADAWUL:1140) Might Deserve Your Attention Today

Second quarter 2024 earnings released: EPS: ر.س0.54 (vs ر.س0.47 in 2Q 2023)

Here's Why We Think Bank Albilad (TADAWUL:1140) Might Deserve Your Attention Today

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Full year 2023 earnings released: EPS: ر.س2.38 (vs ر.س2.09 in FY 2022)

Bank Albilad Recommends to Distribute Cash Dividends for 2023

Here's Why We Think Bank Albilad (TADAWUL:1140) Is Well Worth Watching

Bank Albilad (TADAWUL:1140) Ticks All The Boxes When It Comes To Earnings Growth

Second quarter 2023 earnings: EPS in line with expectations, revenues disappoint

Price target decreased by 8.7% to ر.س38.38

Here's Why We Think Bank Albilad (TADAWUL:1140) Is Well Worth Watching

Consensus EPS estimates fall by 15%

First quarter 2023 earnings: EPS exceeds analyst expectations

Upcoming dividend of ر.س0.50 per share at 1.2% yield

If EPS Growth Is Important To You, Bank Albilad (TADAWUL:1140) Presents An Opportunity

Full year 2022 earnings: EPS misses analyst expectations

Bank Albilad Recommends Cash Dividends for the Year 2022

Do Bank Albilad's (TADAWUL:1140) Earnings Warrant Your Attention?

Less than half of directors are independent

Third quarter 2022 earnings: Revenues in line with analyst expectations

Do Bank Albilad's (TADAWUL:1140) Earnings Warrant Your Attention?

Second quarter 2022 earnings released: EPS: ر.س0.51 (vs ر.س0.42 in 2Q 2021)

Price target increased to ر.س36.95

Here's Why We Think Bank Albilad (TADAWUL:1140) Is Well Worth Watching

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Bank Albilad Announces Executive Changes

Bank Albilad Announces Resignation of Khalid Abdulaziz Almukairin as Board of Directors, with Effect from April 17, 2022

Full year 2021 earnings: EPS misses analyst expectations

Here's Why I Think Bank Albilad (TADAWUL:1140) Is An Interesting Stock

Third quarter 2021 earnings released

Does Bank Albilad (TADAWUL:1140) Deserve A Spot On Your Watchlist?

Price target increased to ر.س38.76

Price target increased to ر.س34.80

Second quarter 2021 earnings released

Here's Why I Think Bank Albilad (TADAWUL:1140) Is An Interesting Stock

First quarter 2021 earnings released: EPS ر.س0.53 (vs ر.س0.36 in 1Q 2020)

Price target increased to ر.س28.98

How Does Bank Albilad (TADAWUL:1140) Fare As A Dividend Stock?

Consensus EPS estimates increase to ر.س2.10

Price target increased to ر.س26.91

Here's Why I Think Bank Albilad (TADAWUL:1140) Is An Interesting Stock

Investors Who Bought Bank Albilad (TADAWUL:1140) Shares Five Years Ago Are Now Up 87%

Full year 2020 earnings released: EPS ر.س1.81 (vs ر.س1.67 in FY 2019)

Revenue and earnings beat expectations

New 90-day high: ر.س29.00

Bank Albilad Announces Management Changes

Bank Albilad Announces Demise of the Chairman of the Board of Directors Abdulrahman Bin Ibrahim Al Humid

What Type Of Shareholders Own The Most Number of Bank Albilad (TADAWUL:1140) Shares?

New 90-day high: ر.س28.85

What Makes Bank Albilad (TADAWUL:1140) A Great Dividend Stock?

New 90-day high: ر.س28.00

Analysts update estimates

Do Bank Albilad's (TADAWUL:1140) Earnings Warrant Your Attention?

Revenue and earnings beat expectations

Third quarter 2020 earnings released: EPS ر.س0.51

Revenue and earnings beat expectations

Third quarter earnings released

New 90-day low: ر.س23.26

Price target raised to ر.س24.47

New 90-day high - ر.س25.50

First half earnings released

New 90-day high - ر.س24.16

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Finansal Kurumlar Analizi

Sağlıklı şirketleri keşfedin